Advancing Treatment in Primary Biliary Cholangitis (PBC): Insights Into a Selective PPARδ Agonist
Nov 10 2025
Convention Center: Exhibit Hall DE - TLM Theater 1
3:30 PM
- 4:15 PM
Description
Join us for a product theater on an FDA-approved treatment option for primary biliary cholangitis (PBC). Gain insights into how this therapy may support improved PBC outcomes for the appropriate patients affected by this chronic liver disease.